3.86
price down icon0.26%   -0.01
after-market 시간 외 거래: 3.87 0.01 +0.26%
loading

Vigil Neuroscience Inc 주식(VIGL)의 최신 뉴스

pulisher
07:05 AM

Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference - GlobeNewswire

07:05 AM
pulisher
04:09 AM

abrdn plc Makes New $799,000 Investment in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

04:09 AM
pulisher
Oct 09, 2024

Vigil Neuroscience retains stock target on TREM2 potential - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Vigil Neuroscience retains stock target on TREM2 potential By Investing.com - Investing.com Australia

Oct 09, 2024
pulisher
Oct 09, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) - Victoria Advocate

Oct 09, 2024
pulisher
Oct 03, 2024

Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors - BioSpace

Oct 03, 2024
pulisher
Oct 02, 2024

Quanterix Appoints Ivana Magovčević-Liebisch to Board of Directors - citybiz

Oct 02, 2024
pulisher
Oct 02, 2024

Point72 Asset Management L.P. Buys New Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Oct 02, 2024
pulisher
Oct 02, 2024

Point72 Asset Management L.P. Acquires New Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

Oct 02, 2024
pulisher
Sep 29, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Shares Purchased by Ensign Peak Advisors Inc - MarketBeat

Sep 29, 2024
pulisher
Sep 27, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Down 20.3% in September - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 23, 2024

Certified Advisory Corp Grows Stake in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Shares Purchased by Harmony Asset Management LLC - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Evergreen Capital Management LLC Sells 380 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Circle Wealth Management LLC Acquires 383 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Garden State Investment Advisory Services LLC Acquires 743 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Vicor Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – VICR - ForexTV.com

Sep 20, 2024
pulisher
Sep 20, 2024

Vigil Neuroscience shares maintain Outperform rating on positive FDA update - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

WCG Wealth Advisors LLC Has $3 Million Position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Bradley Foster & Sargent Inc. CT Cuts Position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

1,275 Shares in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Bought by One Capital Management LLC - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) Shares Sold by ProVise Management Group LLC - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Vigil Neuroscience shares maintain Outperform rating on positive FDA update By Investing.com - Investing.com Australia

Sep 19, 2024
pulisher
Sep 18, 2024

FDA lifts partial clinical hold on Vigil Neuroscience’s Phase I VG-3927 trial - Clinical Trials Arena

Sep 18, 2024
pulisher
Sep 18, 2024

FDA lifts hold on Vigil Neuroscience's Alzheimer trial By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927 - ForexTV.com

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil stock gains as FDA removes partial hold (NASDAQ:VIGL) - Seeking Alpha

Sep 17, 2024
pulisher
Sep 17, 2024

FDA lifts hold on Vigil Neuroscience's Alzheimer trial - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data - TipRanks

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience Says FDA Lifts Partial Hold Alzheimer's-Treatment Trial - MarketWatch

Sep 17, 2024
pulisher
Sep 17, 2024

Vigil Neuroscience rises as FDA lifts partial hold on Alzheimer’s disease trial - XM

Sep 17, 2024
pulisher
Sep 16, 2024

The Neuroscience Market Research Explores 2024: Advancing Brain Research and Therapeutics - WhaTech

Sep 16, 2024
pulisher
Sep 16, 2024

Vigil Neuroscience to Present at Cantor Global Healthcare Conference - GlobeNewswire

Sep 16, 2024
pulisher
Sep 14, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Update - MarketBeat

Sep 14, 2024
pulisher
Sep 14, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Down 23.7% in August - Defense World

Sep 14, 2024
pulisher
Sep 10, 2024

Vigil Neuroscience (NASDAQ:VIGL) Trading 5% Higher - MarketBeat

Sep 10, 2024
pulisher
Sep 02, 2024

Neurodegenerative Disorder Therapeutics Market Insights Discussed Regarding Size And Outlook 2024-2033 - WhaTech

Sep 02, 2024
pulisher
Sep 02, 2024

A stock that deserves closer examination: Vigil Neuroscience Inc (VIGL) - US Post News

Sep 02, 2024
pulisher
Sep 02, 2024

You might want to take a look at Vigil Neuroscience Inc (VIGL) now - SETE News

Sep 02, 2024
pulisher
Aug 29, 2024

Vigil Neuroscience to Present at Upcoming September Investor Conferences - GlobeNewswire

Aug 29, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Acquires 95,276 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Aug 19, 2024
pulisher
Aug 16, 2024

Q3 2024 EPS Estimates for Vigil Neuroscience, Inc. Decreased by Analyst (NASDAQ:VIGL) - MarketBeat

Aug 16, 2024
pulisher
Aug 16, 2024

Research Analysts Offer Predictions for Vigil Neuroscience, Inc.’s Q3 2024 Earnings (NASDAQ:VIGL) - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Vigil Neuroscience (NASDAQ:VIGL) Stock Rating Reaffirmed by HC Wainwright - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Down 20.4% in July - MarketBeat

Aug 16, 2024
pulisher
Aug 15, 2024

Vigil Neuroscience stays 'on-track'; Stifel reaffirms buy rating on stock - Investing.com India

Aug 15, 2024
pulisher
Aug 15, 2024

Vigil Neuroscience stays 'on-track'; Stifel reaffirms buy rating on stock By Investing.com - Investing.com Canada

Aug 15, 2024
pulisher
Aug 15, 2024

Vigil Neuroscience (NASDAQ:VIGL) Price Target Cut to $16.00 by Analysts at Guggenheim - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

HC Wainwright Analysts Cut Earnings Estimates for Vigil Neuroscience, Inc. (NASDAQ:VIGL) - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

FY2027 EPS Estimates for Vigil Neuroscience, Inc. Reduced by HC Wainwright (NASDAQ:VIGL) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

FY2024 Earnings Forecast for Vigil Neuroscience, Inc. (NASDAQ:VIGL) Issued By Wedbush - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

Guggenheim Trims Vigil Neuroscience (NASDAQ:VIGL) Target Price to $16.00 - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

Vigil Neuroscience's (VIGL) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Aug 14, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):